Corvus Pharmaceuticals, Inc. Gains 38.25%
Tue, Sep 21, 2021 at 05:33 PM
Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) jumped higher at $8.53, a gain of 38.2%. On Mon, Sep 20, 2021, CRVS:NASDAQ touched a New 2-Week High of $6.17. The stock appeared on our News Catalysts scanner on Sun, Sep 19, 2021 at 12:03 PM in the 'BIOTECH' category. From Tue, Sep 07, 2021, the stock recorded 55.56% Up Days and 40.00% Green Days
About Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ)
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.
Top 10 Gainers:
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 99.23%
- HLBZ (HLBZ:NASDAQ), 96.59%
- NanoViricides, Inc. (NNVC:NYSEMKT), 63.32%
- ENSC (ENSC:NASDAQ), 48.21%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 38.25%
- NOTV (NOTV:NASDAQ), 35.64%
- NeuroMetrix, Inc. (NURO:NASDAQ), 26.65%
- ARQQ (ARQQ:NASDAQ), 26.58%
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 23.1%
- AMCON Distributing Company (DIT:NYSEMKT), 22.21%